ClinicalTrials.gov (n.d.-d) Assessment of single doses of oral dexanabinol in healthy subjects.

https://ClinicalTrials.gov/show/NCT02054754

ClinicalTrials.gov (n.d.-e) Efcacy and safety of dronabinol in the improvement of chemotherapy-

induced and tumor-related symptoms in advanced pancreatic cancer. https://ClinicalTrials.gov/

show/NCT03984214

ClinicalTrials.gov (n.d.-f) Phase 1 study to evaluate safety and usefulness of an ayurvedic cannabis

preparation in the peri-operative period in breast and oral cavity squamous cell cancer. https://

ClinicalTrials.gov/show/CTRI/2020/06/026049

ClinicalTrials.gov (n.d.-g) Study on cannabinoid receptor expression in gastrointestinal diseases.

https://ClinicalTrials.gov/show/NCT02735941

ClinicalTrials.gov (n.d.-h) TN-TC11G (THC+CBD) combination with temozolomide and radio-

therapy in patients with newly-diagnosed glioblastoma. https://ClinicalTrials.gov/show/NCT03

529448

Colodenco D, Palomares O, Celis C, KaplanA DC (2018) Moving toward consensus on diagnosis

and management of severe asthma in adults. Curr Med Res Opin 34(3):387399

Consroe P, Wolkin A (1977a) Cannabidiol-antiepileptic drug comparisons and interactions in

experimentally induced seizures in rats. J Pharmacol Exp Ther 201:2632

Consroe PF, Wolkin AL (1977b) Anticonvulsant interaction of cannabidiol and ethosuximide in

rats. J Pharm Pharmacol 29:500501

Consroe P, Musty R, Rein J et al (1997) The perceived effects of smoked cannabis on patients with

multiple sclerosis. Eur Neurol 38(1):4448

Cortesi M, Fusar-Poli P (2007) Potential therapeutical effects of cannabidiol in children with

pharmacoresistant epilepsy. Med Hypotheses 68:920921

Curtis A, Rickards H (2006) Nabilone could treat chorea and irritability in Huntington's disease. J

Neuropsychiatry Clin Neurosci 18:553554

Dando I, Donadelli M, Costanzo C, Pozza DE, DAlessandro A, Zolla L et al (2013) Cannabinoids

inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer

cells. Cell Death Dis 4:e664

Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and

characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605613

Esposito G, De Filippis D, Maiuri MC (2006) Cannabidiol inhibits inducible nitric oxide synthase

protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through

p38 MAP kinase and NF-kappaB involvement. Neurosci Lett 399:9195

Esposito G, Scuderi C, Savani C (2007) Cannabidiol in vivo blunts β-amyloid induced

neuroinammation by suppressing IL-1β and iNOS expression. Br J Pharmacol 151:12721279

Fogli S, Nieri P, Chicca A, AdinolB, Mariotti V, Iacopetti P et al (2006) Cannabinoid derivatives

induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. FEBS

Lett 580:17331739

Garcia-Gil L, de Miguel R, Romero J et al (1999) Perinatal delta9-tetrahydrocannabinol exposure

augmented the magnitude of motor inhibition caused by GABA (B), but not GABA (A),

receptor agonists in adult rats. Neurotoxicol Teratol 21(3):277283

Global Initiative for Asthma (2020) Global strategy for asthma management and prevention

Gordon E, Devinsky O (2001) Alcohol and marijuana: effects on epilepsy and use by patients with

epilepsy. Epilepsia 42:12661272

Han KH, Lim S, Ryu J (2009) CB1 and CB2 cannabinoid receptors differentially regulate the

production of reactive oxygen species by macrophages. Cardiovasc Res 84:378386

Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B (2014) Cannabinoids increase lung cancer

cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1. Biochem Pharmacol

92:312325

Holland ML, Panetta JA, Hoskins JM, Bebawy M, Roufogalis BD, Allen JD, Arnold JC (2006) The

effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.

Biochem Pharmacol 71(8):11461154

Holland ML, Lau DTT, Allen JD, Arnold JC (2007) The multidrug transporter ABCG2 (BCRP) is

inhibited by plant-derived cannabinoids. Br J Pharmacol 152(5):815824

198

S. Singh et al.